(E)-2-(5-cyano-N-phenylbenzimidazol-2-yl)-3-(4-N,N-dimethylaminophenyl)acrylonitrile

ID: ALA4855042

PubChem CID: 164616317

Max Phase: Preclinical

Molecular Formula: C25H19N5

Molecular Weight: 389.46

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C)c1ccc(/C=C(\C#N)c2nc3ccc(C#N)cc3n2-c2ccccc2)cc1

Standard InChI:  InChI=1S/C25H19N5/c1-29(2)21-11-8-18(9-12-21)14-20(17-27)25-28-23-13-10-19(16-26)15-24(23)30(25)22-6-4-3-5-7-22/h3-15H,1-2H3/b20-14+

Standard InChI Key:  DFOPSJIOQZRKRZ-XSFVSMFZSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   37.6731  -24.7248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3827  -24.3153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3799  -23.4927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6713  -23.0874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9650  -24.3158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9662  -23.4993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1901  -23.2458    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.7091  -23.9057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1881  -24.5669    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.8919  -23.9045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4843  -23.1962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0741  -22.4858    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.4822  -24.6116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6651  -24.6104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2606  -23.9035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4442  -23.9020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0338  -24.6097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4457  -25.3203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2608  -25.3184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9344  -25.3437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0895  -24.7210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.7978  -25.1285    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.1360  -25.5108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8822  -26.2868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4284  -26.8958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2316  -26.7237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4816  -25.9479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2166  -24.6096    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.8081  -23.9018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8015  -25.3123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  1  0
  8 10  1  0
 10 11  1  0
 11 12  3  0
 10 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
  9 20  1  0
 21 22  3  0
  2 21  1  0
 20 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 20  1  0
 17 28  1  0
 28 29  1  0
 28 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4855042

    ---

Associated Targets(Human)

TERT-RPE1 (415 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAPAN-1 (772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MM1.S (1111 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Z-138 (387 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 389.46Molecular Weight (Monoisotopic): 389.1640AlogP: 5.03#Rotatable Bonds: 4
Polar Surface Area: 68.64Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 4.53CX LogP: 5.54CX LogD: 5.54
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.46Np Likeness Score: -1.57

References

1. Perin N, Hok L, Beč A, Persoons L, Vanstreels E, Daelemans D, Vianello R, Hranjec M..  (2021)  N-substituted benzimidazole acrylonitriles as in vitro tubulin polymerization inhibitors: Synthesis, biological activity and computational analysis.,  211  [PMID:33248847] [10.1016/j.ejmech.2020.113003]

Source